CN101002833A - Medicine for treating psoriasis - Google Patents
Medicine for treating psoriasis Download PDFInfo
- Publication number
- CN101002833A CN101002833A CN 200710019578 CN200710019578A CN101002833A CN 101002833 A CN101002833 A CN 101002833A CN 200710019578 CN200710019578 CN 200710019578 CN 200710019578 A CN200710019578 A CN 200710019578A CN 101002833 A CN101002833 A CN 101002833A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- parts
- medicine
- treating psoriasis
- powdered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 17
- 201000004681 Psoriasis Diseases 0.000 title abstract description 6
- 229940079593 drug Drugs 0.000 title description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 12
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims abstract description 12
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 10
- VOBDXTSTTMAKHK-VHDCPBDGSA-N 3870-07-3 Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)COC(=O)C)[C@@]1(C)C[C@@H]2O VOBDXTSTTMAKHK-VHDCPBDGSA-N 0.000 claims abstract description 6
- 235000000177 Indigofera tinctoria Nutrition 0.000 claims abstract description 6
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 6
- 235000013877 carbamide Nutrition 0.000 claims abstract description 6
- 239000004202 carbamide Substances 0.000 claims abstract description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229940097275 indigo Drugs 0.000 claims abstract description 6
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 claims abstract description 6
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 6
- 239000011709 vitamin E Substances 0.000 claims abstract description 6
- 229940046009 vitamin E Drugs 0.000 claims abstract description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 5
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 5
- 239000011718 vitamin C Substances 0.000 claims abstract description 5
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229910052957 realgar Inorganic materials 0.000 claims abstract description 3
- 235000019158 vitamin B6 Nutrition 0.000 claims abstract description 3
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 3
- 229940011671 vitamin b6 Drugs 0.000 claims abstract description 3
- 230000001185 psoriatic effect Effects 0.000 claims description 7
- 230000000694 effects Effects 0.000 abstract description 7
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- 201000010099 disease Diseases 0.000 description 3
- 206010040882 skin lesion Diseases 0.000 description 3
- 231100000444 skin lesion Toxicity 0.000 description 3
- 239000012467 final product Substances 0.000 description 2
- 210000000088 lip Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 201000009053 Neurodermatitis Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine for treating psoriasis, which is prepared from realgar, natural indigo, salvia miltiorrhiza, triamcinolone acetonide acetate, vitamin E, vitamin B6, vitamin C and urea. The invention has good effect of treating psoriasis, the cure rate reaches 91 percent, and the total effective rate is 100 percent.
Description
Technical field:
The present invention relates to a kind of medicine, is the psoriatic medicine of treatment.
Background technology:
Not clear to the psoriatic cause of disease at present, thereby it is also few on China's pharmaceutical market to treating psoriatic medicament categories, existing medicine is hormone drugs mostly, the quasi drugs of Chinese patent medicine, and Therapeutic Method such as Chinese medicine for oral administration decoction and physical therapy, also have some anti-swollen medicines (because of toxic and side effects big, now few doctor uses), but above these medicines are used on one's body the patient, and the overwhelming majority does not play much effects, therefore, to the treatment of this disease, have only the medical personnel on each medical battle line, each doing his best in performance, the treatment method of the length of each skill, treat the dermatosis that this obstinate difficulty heals, but, generally speaking, do not reach ideal therapeutic effect far away.
Summary of the invention:
The object of the present invention is to provide a kind of psoriatic medicine of the effective treatment of psoriasis for the treatment of.
Technical solution of the present invention is:
The psoriatic medicine of a kind of treatment, it is characterized in that: the component by following weight portion is made:
5～10 parts of 2～5 parts of Indigo Naturaliss of Realgar
0.05～0.1 part of 5～10 parts of triamcinolone acetonide acetate of Radix Salviae Miltiorrhizae
0.05～0.1 part of 0.5～1.0 part of vitamin B6 of vitamin E
5～10 parts in 0.5～1.0 part of carbamide of vitamin C.
It is effective that the present invention treats psoriasis, according to statistics, and through psoriasis people 213 philtrums of the present invention's treatment, first visit patient 98 people are through invalid excessively patient 115 people of hospitalize, wherein through 45 people of 1 hospitalize, through 28 people of 2 hospitalizes, through 41 people of 3～7 hospitalizes.213 philtrums are cured 194 people of (complete) after Drug therapy of the present invention, cure rate reaches 91%, and (criterion of therapeutical effect: complete: skin lesion all disappears total effective rate 100%, and skin recovers normal or leaves temporary pigmented spots; Produce effects: skin lesion disappears more than 70%; Effectively: skin lesion disappears 40～70%; Produce effects with effectively add up to effective percentage.)。This medicine has positive effect equally to treatment seborrheic dermatitis, neurodermatitis, skin itching disease and wet disease, newborn diapers dermatitis etc., can very fast recovery from illness.
The present invention is easy to use, is applied to the affected part 2～3 times on the 1st to get final product, and curative effect is outstanding, and is safe and reliable, economic actual effect.
The invention will be further described below in conjunction with embodiment.
The specific embodiment:
Embodiment 1:
The each component of following weight portion fully is mixed and made into product:
2 parts of Realgars (Powdered), 7 parts of Indigo Naturaliss (Powdered), 10 parts of Radix Salviae Miltiorrhizaes (Powdered), 0.05 part of triamcinolone acetonide acetate, 0.5 part of vitamin E, 0.08 part of vitamin B6,1.0 parts of vitamin Cs, 10 parts in carbamide.Be applied to the affected part and get final product for 2～3 times on the 1st.
Embodiment 2:
Each components by weight percent consumption is:
3 parts of Realgars (Powdered), 10 parts of Indigo Naturaliss (Powdered), 7 parts of Radix Salviae Miltiorrhizaes (Powdered), 0.08 part of triamcinolone acetonide acetate, 0.8 part of vitamin E, 0.05 part of vitamin B6,0.5 part of vitamin C, 8 parts in carbamide.All the other are with embodiment 1.
Embodiment 3:
Each components by weight percent consumption is:
5 parts of Realgars (Powdered), 5 parts of Indigo Naturaliss (Powdered), 5 parts of Radix Salviae Miltiorrhizaes (Powdered), 0.1 part of triamcinolone acetonide acetate, 1 part of vitamin E, 0.1 part of vitamin B6,0.8 part of vitamin C, 5 parts in carbamide.All the other are with embodiment 1.
Claims (1)
1, the psoriatic medicine of a kind of treatment, it is characterized in that: the component by following weight portion is made:
5～10 parts of 2～5 parts of Indigo Naturaliss of Realgar
0.05～0.1 part of 5～10 parts of triamcinolone acetonide acetate of Radix Salviae Miltiorrhizae
0.05～0.1 part of 0.5～1.0 part of vitamin B6 of vitamin E
5～10 parts in 0.5～1.0 part of carbamide of vitamin C.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2007100195781A CN100551394C (en) | 2007-01-19 | 2007-01-19 | Medicine for treating psoriasis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2007100195781A CN100551394C (en) | 2007-01-19 | 2007-01-19 | Medicine for treating psoriasis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101002833A true CN101002833A (en) | 2007-07-25 |
| CN100551394C CN100551394C (en) | 2009-10-21 |
Family
ID=38702359
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2007100195781A Expired - Fee Related CN100551394C (en) | 2007-01-19 | 2007-01-19 | Medicine for treating psoriasis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100551394C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101890042A (en) * | 2009-05-18 | 2010-11-24 | 上海交通大学医学院附属瑞金医院 | Chinese medicinal compound preparation arsenic tetrasulfide-tanshinone-indirubin and preparation method thereof and application thereof in preparing antineoplastic agents |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012058826A1 (en) * | 2010-11-05 | 2012-05-10 | Ma Xuerong | Medicine for treating psoriasis |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1318395A (en) * | 2000-04-19 | 2001-10-24 | 黄波 | Dermatosis treating medicine and its preparation |
| CN1225254C (en) * | 2002-05-09 | 2005-11-02 | 淄博市职业病防治院 | Medicinal composition, its preparation process and use in treating psoriasis |
-
2007
- 2007-01-19 CN CNB2007100195781A patent/CN100551394C/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101890042A (en) * | 2009-05-18 | 2010-11-24 | 上海交通大学医学院附属瑞金医院 | Chinese medicinal compound preparation arsenic tetrasulfide-tanshinone-indirubin and preparation method thereof and application thereof in preparing antineoplastic agents |
| CN101890042B (en) * | 2009-05-18 | 2013-06-19 | 上海交通大学医学院附属瑞金医院 | Chinese medicinal compound preparation arsenic tetrasulfide-tanshinone-indirubin and preparation method thereof and application thereof in preparing antineoplastic agents |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100551394C (en) | 2009-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101167847B (en) | Traditional Chinese medicinal white spirit preparation for effectively treating skin disease | |
| CN101513522B (en) | Chinese medical herbs aerosols for treating anchylosis, painful swelling and preparation method thereof | |
| CN103394031B (en) | Medicament for treating sciatica | |
| CN1927286A (en) | Chinese medicine composition for treating skin disease | |
| CN100551394C (en) | Medicine for treating psoriasis | |
| CN101721651B (en) | Traditional Chinese medicine capsule for treating scapulohumeral periarthritis | |
| CN103405602A (en) | Medicament for treating asthma | |
| CN103845559A (en) | Traditional Chinese medicine for arthralgia and myalgia | |
| CN102670919A (en) | Chinese medicament for treating chronic pyelonephritis | |
| CN102370853A (en) | Traditional Chinese medicine for treating chronic pyelonephritis | |
| CN102228559B (en) | Externally applied ointment for treating children eczema | |
| CN101983712A (en) | Novel medicament for treating coronary heart disease | |
| CN101897888A (en) | Traditional Chinese medicine for treating rheumatic heart disease | |
| CN101912566B (en) | Traditional Chinese medicine for treating palpitation | |
| CN101953999B (en) | Medicinal composition for treating paralysis and preparation method thereof | |
| CN107007755A (en) | A kind of preparation method of bruise spray | |
| CN101185697B (en) | Ointment medicine for treating anal fissure | |
| CN101773590A (en) | Chinese drug capsule for treatment of coronary heart disease with qi deficiency and blood stasis | |
| CN101313930A (en) | Plaster medicament for treating erosion type tinea manus and pedis | |
| CN106074784A (en) | The Chinese medicine for the treatment of coronary heart disease and myocardial ischemia | |
| CN104688901A (en) | Traditional Chinese medicine topical agent for preventing constipation of patients with acute myocardial infarction and nursing method | |
| CN102895468B (en) | Traditional Chinese medicine (TCM) preparation for treating psoriasis and preparation method | |
| CN101199695B (en) | Powders medicament for treating sinusitis | |
| CN108114265A (en) | The external traditional Chinese medicine ointment of cure scapulohumeral periarthritis | |
| CN101979010A (en) | Chinese medicament for treating metrorrhagia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20091021 Termination date: 20150119 |
|
| EXPY | Termination of patent right or utility model |